Cargando…

Immune Responses in Fully Vaccinated Individuals Following Breakthrough Infection with the SARS-CoV-2 Delta Variant in Provincetown, Massachusetts

BACKGROUND: A cluster of over a thousand infections with the SARS-CoV-2 delta variant was identified in a predominantly fully vaccinated population in Provincetown, Massachusetts in July 2021. Immune responses in breakthrough infections with the SARS-CoV-2 delta variant remain to be defined. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Collier, Ai-ris Y., Brown, Catherine M., Mcmahan, Katherine, Yu, Jingyou, Liu, Jinyan, Jacob-Dolan, Catherine, Chandrashekar, Abishek, Tierney, Dylan, Ansel, Jessica L., Rowe, Marjorie, Sellers, Daniel, Ahmad, Kunza, Aguayo, Ricardo, Anioke, Tochi, Gardner, Sarah, Siamatu, Mazuba, Bermudez Rivera, Lorraine, Hacker, Michele R., Madoff, Lawrence C., Barouch, Dan H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547536/
https://www.ncbi.nlm.nih.gov/pubmed/34704104
http://dx.doi.org/10.1101/2021.10.18.21265113
_version_ 1784590398243471360
author Collier, Ai-ris Y.
Brown, Catherine M.
Mcmahan, Katherine
Yu, Jingyou
Liu, Jinyan
Jacob-Dolan, Catherine
Chandrashekar, Abishek
Tierney, Dylan
Ansel, Jessica L.
Rowe, Marjorie
Sellers, Daniel
Ahmad, Kunza
Aguayo, Ricardo
Anioke, Tochi
Gardner, Sarah
Siamatu, Mazuba
Bermudez Rivera, Lorraine
Hacker, Michele R.
Madoff, Lawrence C.
Barouch, Dan H.
author_facet Collier, Ai-ris Y.
Brown, Catherine M.
Mcmahan, Katherine
Yu, Jingyou
Liu, Jinyan
Jacob-Dolan, Catherine
Chandrashekar, Abishek
Tierney, Dylan
Ansel, Jessica L.
Rowe, Marjorie
Sellers, Daniel
Ahmad, Kunza
Aguayo, Ricardo
Anioke, Tochi
Gardner, Sarah
Siamatu, Mazuba
Bermudez Rivera, Lorraine
Hacker, Michele R.
Madoff, Lawrence C.
Barouch, Dan H.
author_sort Collier, Ai-ris Y.
collection PubMed
description BACKGROUND: A cluster of over a thousand infections with the SARS-CoV-2 delta variant was identified in a predominantly fully vaccinated population in Provincetown, Massachusetts in July 2021. Immune responses in breakthrough infections with the SARS-CoV-2 delta variant remain to be defined. METHODS: Humoral and cellular immune responses were assessed in 35 vaccinated individuals who were tested for SARS-CoV-2 in the Massachusetts Department of Public Health outbreak investigation. RESULTS: Vaccinated individuals who tested positive for SARS-CoV-2 demonstrated substantially higher antibody responses than vaccinated individuals who tested negative for SARS-CoV-2, including 28-fold higher binding antibody titers and 34-fold higher neutralizing antibody titers against the SARS-CoV-2 delta variant. Vaccinated individuals who tested positive also showed 4.4-fold higher Spike-specific CD8+ T cell responses against the SARS-CoV-2 delta variant than vaccinated individuals who tested negative. CONCLUSIONS: Fully vaccinated individuals developed robust anamnestic antibody and T cell responses following infection with the SARS-CoV-2 delta variant. These data suggest important immunologic benefits of vaccination in the context of breakthrough infections.
format Online
Article
Text
id pubmed-8547536
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cold Spring Harbor Laboratory
record_format MEDLINE/PubMed
spelling pubmed-85475362021-10-27 Immune Responses in Fully Vaccinated Individuals Following Breakthrough Infection with the SARS-CoV-2 Delta Variant in Provincetown, Massachusetts Collier, Ai-ris Y. Brown, Catherine M. Mcmahan, Katherine Yu, Jingyou Liu, Jinyan Jacob-Dolan, Catherine Chandrashekar, Abishek Tierney, Dylan Ansel, Jessica L. Rowe, Marjorie Sellers, Daniel Ahmad, Kunza Aguayo, Ricardo Anioke, Tochi Gardner, Sarah Siamatu, Mazuba Bermudez Rivera, Lorraine Hacker, Michele R. Madoff, Lawrence C. Barouch, Dan H. medRxiv Article BACKGROUND: A cluster of over a thousand infections with the SARS-CoV-2 delta variant was identified in a predominantly fully vaccinated population in Provincetown, Massachusetts in July 2021. Immune responses in breakthrough infections with the SARS-CoV-2 delta variant remain to be defined. METHODS: Humoral and cellular immune responses were assessed in 35 vaccinated individuals who were tested for SARS-CoV-2 in the Massachusetts Department of Public Health outbreak investigation. RESULTS: Vaccinated individuals who tested positive for SARS-CoV-2 demonstrated substantially higher antibody responses than vaccinated individuals who tested negative for SARS-CoV-2, including 28-fold higher binding antibody titers and 34-fold higher neutralizing antibody titers against the SARS-CoV-2 delta variant. Vaccinated individuals who tested positive also showed 4.4-fold higher Spike-specific CD8+ T cell responses against the SARS-CoV-2 delta variant than vaccinated individuals who tested negative. CONCLUSIONS: Fully vaccinated individuals developed robust anamnestic antibody and T cell responses following infection with the SARS-CoV-2 delta variant. These data suggest important immunologic benefits of vaccination in the context of breakthrough infections. Cold Spring Harbor Laboratory 2021-10-20 /pmc/articles/PMC8547536/ /pubmed/34704104 http://dx.doi.org/10.1101/2021.10.18.21265113 Text en https://creativecommons.org/licenses/by-nd/4.0/This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nd/4.0/) , which allows reusers to copy and distribute the material in any medium or format in unadapted form only, and only so long as attribution is given to the creator. The license allows for commercial use.
spellingShingle Article
Collier, Ai-ris Y.
Brown, Catherine M.
Mcmahan, Katherine
Yu, Jingyou
Liu, Jinyan
Jacob-Dolan, Catherine
Chandrashekar, Abishek
Tierney, Dylan
Ansel, Jessica L.
Rowe, Marjorie
Sellers, Daniel
Ahmad, Kunza
Aguayo, Ricardo
Anioke, Tochi
Gardner, Sarah
Siamatu, Mazuba
Bermudez Rivera, Lorraine
Hacker, Michele R.
Madoff, Lawrence C.
Barouch, Dan H.
Immune Responses in Fully Vaccinated Individuals Following Breakthrough Infection with the SARS-CoV-2 Delta Variant in Provincetown, Massachusetts
title Immune Responses in Fully Vaccinated Individuals Following Breakthrough Infection with the SARS-CoV-2 Delta Variant in Provincetown, Massachusetts
title_full Immune Responses in Fully Vaccinated Individuals Following Breakthrough Infection with the SARS-CoV-2 Delta Variant in Provincetown, Massachusetts
title_fullStr Immune Responses in Fully Vaccinated Individuals Following Breakthrough Infection with the SARS-CoV-2 Delta Variant in Provincetown, Massachusetts
title_full_unstemmed Immune Responses in Fully Vaccinated Individuals Following Breakthrough Infection with the SARS-CoV-2 Delta Variant in Provincetown, Massachusetts
title_short Immune Responses in Fully Vaccinated Individuals Following Breakthrough Infection with the SARS-CoV-2 Delta Variant in Provincetown, Massachusetts
title_sort immune responses in fully vaccinated individuals following breakthrough infection with the sars-cov-2 delta variant in provincetown, massachusetts
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547536/
https://www.ncbi.nlm.nih.gov/pubmed/34704104
http://dx.doi.org/10.1101/2021.10.18.21265113
work_keys_str_mv AT collierairisy immuneresponsesinfullyvaccinatedindividualsfollowingbreakthroughinfectionwiththesarscov2deltavariantinprovincetownmassachusetts
AT browncatherinem immuneresponsesinfullyvaccinatedindividualsfollowingbreakthroughinfectionwiththesarscov2deltavariantinprovincetownmassachusetts
AT mcmahankatherine immuneresponsesinfullyvaccinatedindividualsfollowingbreakthroughinfectionwiththesarscov2deltavariantinprovincetownmassachusetts
AT yujingyou immuneresponsesinfullyvaccinatedindividualsfollowingbreakthroughinfectionwiththesarscov2deltavariantinprovincetownmassachusetts
AT liujinyan immuneresponsesinfullyvaccinatedindividualsfollowingbreakthroughinfectionwiththesarscov2deltavariantinprovincetownmassachusetts
AT jacobdolancatherine immuneresponsesinfullyvaccinatedindividualsfollowingbreakthroughinfectionwiththesarscov2deltavariantinprovincetownmassachusetts
AT chandrashekarabishek immuneresponsesinfullyvaccinatedindividualsfollowingbreakthroughinfectionwiththesarscov2deltavariantinprovincetownmassachusetts
AT tierneydylan immuneresponsesinfullyvaccinatedindividualsfollowingbreakthroughinfectionwiththesarscov2deltavariantinprovincetownmassachusetts
AT anseljessical immuneresponsesinfullyvaccinatedindividualsfollowingbreakthroughinfectionwiththesarscov2deltavariantinprovincetownmassachusetts
AT rowemarjorie immuneresponsesinfullyvaccinatedindividualsfollowingbreakthroughinfectionwiththesarscov2deltavariantinprovincetownmassachusetts
AT sellersdaniel immuneresponsesinfullyvaccinatedindividualsfollowingbreakthroughinfectionwiththesarscov2deltavariantinprovincetownmassachusetts
AT ahmadkunza immuneresponsesinfullyvaccinatedindividualsfollowingbreakthroughinfectionwiththesarscov2deltavariantinprovincetownmassachusetts
AT aguayoricardo immuneresponsesinfullyvaccinatedindividualsfollowingbreakthroughinfectionwiththesarscov2deltavariantinprovincetownmassachusetts
AT anioketochi immuneresponsesinfullyvaccinatedindividualsfollowingbreakthroughinfectionwiththesarscov2deltavariantinprovincetownmassachusetts
AT gardnersarah immuneresponsesinfullyvaccinatedindividualsfollowingbreakthroughinfectionwiththesarscov2deltavariantinprovincetownmassachusetts
AT siamatumazuba immuneresponsesinfullyvaccinatedindividualsfollowingbreakthroughinfectionwiththesarscov2deltavariantinprovincetownmassachusetts
AT bermudezriveralorraine immuneresponsesinfullyvaccinatedindividualsfollowingbreakthroughinfectionwiththesarscov2deltavariantinprovincetownmassachusetts
AT hackermicheler immuneresponsesinfullyvaccinatedindividualsfollowingbreakthroughinfectionwiththesarscov2deltavariantinprovincetownmassachusetts
AT madofflawrencec immuneresponsesinfullyvaccinatedindividualsfollowingbreakthroughinfectionwiththesarscov2deltavariantinprovincetownmassachusetts
AT barouchdanh immuneresponsesinfullyvaccinatedindividualsfollowingbreakthroughinfectionwiththesarscov2deltavariantinprovincetownmassachusetts